Imitation is suicide
Peter co-founded Lux Capital with the idea that in order to have the biggest impact on the future, one should support the most scientifically and technologically ambitious ventures. His goal: to seek out founders developing things most people thought would not work, yet if they did, would become so intrinsic to our way of life that we would someday take them for granted.
Today Lux supports a wide range of once-impossible-sounding advancements, including 3D printing and imaging, nuclear waste cleanup, machine learning and robots that fly or conduct microsurgery.
Peter led Lux’s investments in Auris Health (acquired by Johnson & Johnson for up to $6 billion, making it one of top 10 VC-backed private M&A transactions of all-time), Everspin Technologies (NASDAQ: MRAM), Lux Research (acquired by Bregal Sagemount), Luxtera (acquired by Cisco for $660 million), Matterport (NASDAQ: MTTR), SiBEAM (acquired by Silicon Image), Transphorm, and Vium (acquired by Recursion). Current investments include Avail, Bright Machines, Carbon Health, Flex Logix, Lux Health Tech Acquisition Corp. (NASDAQ: LUXA), Ingenuity, Mendaera, and Ripcord. In 2003, Peter led the spin-off of Lux Research. As its founding CEO, he helped build Lux Research into the leading emerging-technology research firm.
Peter began his career at Lehman Brothers, where he worked in the firm’s top-ranked Equity Research group. He was a Chancellor’s Scholar and graduated cum laude from Syracuse University’s Newhouse School, and was the Founding President of its first venture organization, Future Business Leaders and Entrepreneurs. He has been a guest on CNBC and Bloomberg TV, and speaker at Columbia, Cornell, MIT, Stanford, Yale, and the National Science Foundation.
Founded Lux Research; launched Lux Nanotech Index & PowerShares Lux Nanotech Portfolio (NYSE: PXN)
Co-founded Young Wall Street, an organization supporting youth-related causes in New York City
Imitation is suicide Ralph Waldo Emerson